Menlo Park, CA, United States of America

Charles G Vontz

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Topica Pharmaceuticals, Inc.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles G Vontz. Retrieved from https://idiyas.com/inventor/charles-g-vontz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Charles G. Vontz

Introduction

Charles G. Vontz is an accomplished inventor based in Menlo Park, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-fungal formulations. With a total of 3 patents to his name, Vontz continues to push the boundaries of innovation in his industry.

Latest Patents

Among his latest patents is an anti-fungal formulation that provides compositions and formulations comprising an antifungal agent. This pharmaceutical composition includes luliconazole in an amount effective for the treatment of onychomycosis. Additionally, the patent outlines methods for treating dermatomycoses and onychomycosis using these compositions and formulations.

Career Highlights

Vontz is currently associated with Topica Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work focuses on creating effective treatments for fungal infections, which can significantly improve patient outcomes.

Collaborations

Some of his notable coworkers include Norifumi Nakamura and Catherine De Porceri-Morton. Their collaborative efforts contribute to the innovative environment at Topica Pharmaceuticals, Inc.

Conclusion

Charles G. Vontz exemplifies the spirit of innovation in the pharmaceutical industry through his dedicated work and impactful patents. His contributions continue to pave the way for advancements in the treatment of fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…